Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh

Environmental Health Perspectives

Volumn 113, Issue 12, 2005, Pages 1683-1688

  Gamble, Mary V ^a   Liu, Xinhua ^a   Ahsan, Habibul ^a   Pilsner, J Richard ^a   Illievski, Vesna ^a   Slavkovich, Vesna ^a   Parvez, Faruque ^a   Levy, Diane ^a   Factor Litvak, Pam ^a   Graziano, Joseph H ^a,b  

^a Columbia University ^*  (United States)

^b NONE   (United States)

Author keywords

Arsenic; Arsenicosis; Bangladesh; Creatinine; Dimethylarsinic acid; Folate; Homocysteine; Hyperhomocysteinemia; Micronutrient deficiency; Monomethylarsonic acid; One carbon metabolism; S adenosylmethionine; Vitamin B12 well water

Indexed keywords

ARSENIC; COBALAMIN; CREATININE; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; BANGLADESH; CREATININE URINE LEVEL; ENVIRONMENTAL EXPOSURE; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; METABOLITE; METHYLATION; NUTRITIONAL STATUS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; WATER ANALYSIS; WATER CONTAMINATION;

EID: 29144519404     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.8084     Document Type: Article

References (44)

1. Ahmad S, Anderson WL, Kitchin KT. 1999. Dimethylarsinic acid effects on DNA damage and oxidative stress related biochemical parameters in B6C3F1 mice. Cancer Lett 139:129-135.
2. Ahsan H, Chen Y, Parvez F, Zablotska L, Argos L, Hussain A, et al. 2005. Health Effects of Arsenic Longitudinal Study (HEALS): a multidisciplinary epidemiologic investigation. J Expos Anal Environ Epidemiol doi: 10.1038/sj.jea.7500449 [Online 14 September 2005].
3. Ahsan H, Perrin M, Rahman A, Parvez F, Stute M, Zheng Y, et al. 2000. Associations between drinking water and urinary arsenic levels and skin lesions in Bangladesh. J Occup Environ Med 42:1195-1201.
4. Arnadottir M, Hultberg B, Nilsson-Ehle P, Thysell H. 1996. The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. Scand J Clin Lab Invest 56:41-46.
5. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. 2005. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 113:192-200.
6. Brattstrom L, Lindgren A, Israelsson B, Andersson A, Hultberg B. 1994. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 236:633-641.
7. Celkova A, Kubova J, Stresko V. 1996. Determination of arsenic in geological samples by HG AAS. Anal Bioanal Chem 355:150-153.
8. Chen YC, Guo YL, Su HJ, Hsueh YM, Smith TJ, Ryan LM, et al. 2003a. Arsenic methylation and skin cancer risk in southwestern Taiwan. J Occup Environ Med 45:241-248.
9. Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, Ryan LM, et al. 2003b. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 14:303-310.
10. Chiou HY, Huang WI, Su CL, Chang SF, Hsu YH, Chen CJ. 1997. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 28:1717-1723.
11. Chung JS, Kalman DA, Moore LE, Kosnett MJ, Arroyo AP, Beeris M, et al. 2002. Family correlations of arsenic methylation patterns in children and parents exposed to high concentrations of arsenic in drinking water. Environ Health Perspect 110:729-733.
12. De Kimpe J, Cornelis R, Vanholder R. 1999. In vitro methylation of arsenite by rabbit liver cytosol: effect of metal ions, metal chelating agents, methyltransferase inhibitors and uremic toxins. Drug Chem Toxicol 22:613-628.
13. Gamble MV, Ahsan H, Liu X, Factor-Litvak P, Ilievski V, Slavkovich V, et al. 2005. Folate and cobalamin deficiencies and hyperhomocysteinemia in Bangladesh. Am J Clin Nutr 81:1372-1377.
14. Gamble MV, Liu X. 2005. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements [Letter]. Environ Health Perspect 113:A442.
15. Harvey CF, Swartz CH, Badruzzaman AB, Keon-Blute N, Yu W, Ali MA, et al. 2002. Arsenic mobility and groundwater extraction in Bangladesh. Science 298:1602-1606.
16. Hsueh YM, Chiou HY, Huang YL, Wu WL, Huang CC, Yang MH, et al. 1997. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiol Biomarkers Prev 6:589-596.
17. Jones DP, Go YM, Anderson CL, Ziegler TR, Kinkade JM Jr, Kirlin WG. 2004. Cysteine/cystine couple is a newly recognized node in the circuitry for biologic redox signaling and control. FASEB J 18:1246-1248.
18. Kristiansen J, Christensen JM, Iversen BS, Sabbioni E. 1997. Toxic trace element reference levels in blood and urine: influence of gender and lifestyle factors. Sci Total Environ 204:147-160.
19. Lee TC, Tanaka N, Lamb PW, Gilmer TM, Barrett JC. 1988. Induction of gene amplification by arsenic. Science 241:79-81.
20. Lin S, Shi Q, Nix FB, Styblo M, Beck MA, Herbin-Davis KM, et al. 2002. A novel S-adenosyl-L-methionine: arsenic(III) methyltransferase from rat liver cytosol. J Biol Chem 277:10795-10803.
21. Mass MJ, Wang L. 1997. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat Res 386:263-277.
22. Mitra SR, Mazumder DN, Basu A, Block G, Haque R, Samanta S, et al. 2004. Nutritional factors and susceptibility to arseniccaused skin lesions in West Bengal, India. Environ Health Perspect 112:1104-1109.
23. Modd SH, Poole JR. 1975. Labile methyl balances for normal humans on various dietary regimens. Metabolism 24:721-735.
24. Nesnow S, Roop BC, Lambert G, Kadiiska M, Mason RP, Cullen WR, et al. 2002. DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem Res Toxicol 15:1627-1634.
25. Nixon D, Mussmann G, Eckdahl S, Moyer T. 1991. Total arsenic in urine: palladium-persulfate vs nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry. Clin Chem 37:1575-1579.
26. Pfeiffer CM, Huff DL, Gunter EW. 1999. Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting. Clin Chem 45:290-292.
27. Schutte JE, Longhurst JC, Gaffney FA, Bastian BC, Blomqvist CG. 1981. Total plasma creatinine: an accurate measure of total striated muscle mass. J Appl Physiol 51:762-766.
28. Shalat SL, Walker DB, Finnell RH. 1996. Role of arsenic as a reproductive toxin with particular attention to neural tube defects. J Toxicol Environ Health 48:253-272.
29. Spiegelstein O, Lu X, Le XC, Troen A, Selhub J, Melnyk S, et al. 2003. Effects of dietary folate intake and folate binding protein-1 (Folbp1) on urinary speciation of sodium arsenate in mice. Toxicol Lett 145:167-174.
30. Spiegelstein O, Lu X, Le CX, Troen A, Selhub J, Melnyk S, et al. 2005. Effects of dietary folate intake and folate binding protein-2 (Folbp2) on urinary speciation of sodium arsenate in mice. Environ Toxicol Pharmacol 19:1-7.
31. Styblo M, Drobna Z, Jaspers I, Lin S, Thomas DJ. 2002. The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ Health Perspect 110(suppl 5):767-771.
32. Tice RR, Yager JW, Andrews P, Crecelius E. 1997. Effect of hepatic methyl donor status on urinary excretion and DNA damage in B6C3F1 mice treated with sodium arsenite. Mutat Res 386:315-334.
33. U.S. EPA. 2001. National Primary Drinking Water Regulations; Arsenic and Clarifications to Compliance and New Source Contaminants Monitoring; Final Rule. Fed Reg 66(14):6975-7066. Available: http://www.epa.gov/safewater/ars/arsenic_finalrule.pdf [accessed 24 October 2005].
34. Vahter M, Marafante E. 1987. Effects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit. Toxicol Lett 37:41-46.
35. van Geen A, Ahsan H, Horneman AH, Dhar RK, Zheng Y, Hussain I, et al. 2002. Promotion of well-switching to mitigate the current arsenic crisis in Bangladesh. Bull WHO 80:732-737.
36. Vela NP, Heitkemper DT, Stewart KR. 2001. Arsenic extraction and speciation in carrots using accelerated solvent extraction, liquid chromatography and plasma mass spectrometry. Analyst 126:1011-1017.
37. Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, van Geen A, et al. 2004. Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect 112:1329-1333.
38. WHO. 2004. Guidelines for Drinking Water Quality. 3rd Ed, Vol. 1, Recommendations. Geneva:World Health Organization.
39. Wlodarczyk B, Spiegelstein O, Gelineau-van WJ, Vorce RL, Lu X, Le CX, et al. 2001. Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice. Toxicol Appl Pharmacol 177:238-246.
40. Wollesen F, Brattstrom L, Refsum H, Ueland PM, Berglund L, Berne C. 1999. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int 55:1028-1035.
41. Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ. 2000. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 275:29318-29323.
42. Yu RC, Hsu KH, Chen CJ, Froines JR. 2000. Arsenic methylation capacity and skin cancer. Cancer Epidemiol Biomarkers Prev 9:1259-1262.
43. Zakharyan RA, Sampayo-Reyes A, Healy SM, Tsaprailis G, Board PG, Liebler DC, et al. 2001. Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily. Chem Res Toxicol 14:1051-1057.
44. Zakharyan R, Wu Y, Bogdan GM, Aposhian HV. 1995. Enzymatic methylation of arsenic compounds: assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver. Chem Res Toxicol 8:1029-1038.